Anna-Lena Nilsson

1.1k total citations
18 papers, 802 citations indexed

About

Anna-Lena Nilsson is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Anna-Lena Nilsson has authored 18 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Anna-Lena Nilsson's work include Diabetes and associated disorders (6 papers), Pancreatic function and diabetes (5 papers) and Diabetes Management and Research (3 papers). Anna-Lena Nilsson is often cited by papers focused on Diabetes and associated disorders (6 papers), Pancreatic function and diabetes (5 papers) and Diabetes Management and Research (3 papers). Anna-Lena Nilsson collaborates with scholars based in Sweden, United States and Netherlands. Anna-Lena Nilsson's co-authors include Annelie Carlsson, Michael J. Nissen, Carola Saloranta, Aaro Miettinen, Leif Groop, Kaj Lahti, Bo Isomaa, Marja‐Riitta Taskinen, Birgitta Ehrnström and Carol Forsblom and has published in prestigious journals such as Diabetes, Gut and Journal of General Virology.

In The Last Decade

Anna-Lena Nilsson

17 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna-Lena Nilsson Sweden 11 500 491 369 88 86 18 802
G Multari Italy 13 321 0.6× 256 0.5× 265 0.7× 30 0.3× 15 0.2× 36 556
Johanne Le Beyec France 20 177 0.4× 354 0.7× 94 0.3× 58 0.7× 69 0.8× 41 902
Lars Hansen Denmark 12 314 0.6× 437 0.9× 368 1.0× 25 0.3× 5 0.1× 18 775
Kristen A. McDaniel United States 10 334 0.7× 282 0.6× 224 0.6× 16 0.2× 11 0.1× 16 552
Tarunmeet Gujral United States 9 62 0.1× 112 0.2× 50 0.1× 26 0.3× 54 0.6× 12 309
Deng Ping Yin United States 10 89 0.2× 252 0.5× 100 0.3× 56 0.6× 9 0.1× 16 479
Anna Casselbrant Sweden 17 28 0.1× 350 0.7× 119 0.3× 25 0.3× 109 1.3× 54 703
Benedikt A. Aulinger United States 11 70 0.1× 182 0.4× 270 0.7× 27 0.3× 12 0.1× 18 444
Jessica L. Hill United States 9 119 0.2× 120 0.2× 69 0.2× 61 0.7× 7 0.1× 20 440
Marko Banić Croatia 10 40 0.1× 263 0.5× 20 0.1× 51 0.6× 105 1.2× 42 450

Countries citing papers authored by Anna-Lena Nilsson

Since Specialization
Citations

This map shows the geographic impact of Anna-Lena Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Lena Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Lena Nilsson more than expected).

Fields of papers citing papers by Anna-Lena Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Lena Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Lena Nilsson. The network helps show where Anna-Lena Nilsson may publish in the future.

Co-authorship network of co-authors of Anna-Lena Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Lena Nilsson. A scholar is included among the top collaborators of Anna-Lena Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Lena Nilsson. Anna-Lena Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kakuda, Thomas N., Annemie Buelens, Ariane Kahnt, et al.. (2025). Pharmacokinetics, Safety, and Tolerability of Different Maintenance Dose Regimens of Mosnodenvir (JNJ‐1802) in Healthy Adult Participants. Clinical Pharmacology in Drug Development. 14(12). 960–970.
2.
Bergemann, N., Berglind Jónsdóttir, Anna-Lena Nilsson, Mikael Lantz, & A. R. Lind. (2023). Prevalence of Thyroid Peroxidase and Thyroglobulin Autoantibodies in the Swedish Population. Experimental and Clinical Endocrinology & Diabetes. 131(9). 456–462. 2 indexed citations
3.
McDonald, Sharla, Marlena Maziarz, William C. Weldon, et al.. (2021). Neutralizing Ljungan virus antibodies in children with newly diagnosed type 1 diabetes. Journal of General Virology. 102(5). 4 indexed citations
4.
Lind, A. R., Anita Ramelius, Tomas Olsson, et al.. (2014). A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009–2010. Journal of Autoimmunity. 50. 99–106. 38 indexed citations
5.
Nilsson, Anna-Lena, Fariba Vaziri‐Sani, Cecilia Andersson, et al.. (2013). Relationship Between Ljungan Virus Antibodies, HLA-DQ8, and Insulin Autoantibodies in Newly Diagnosed Type 1 Diabetes Children. Viral Immunology. 26(3). 207–215. 13 indexed citations
6.
Andersson, Cecilia, K. Larsson, Fariba Vaziri‐Sani, et al.. (2011). The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity. 44(5). 394–405. 65 indexed citations
7.
Larsson, K., Eva Örtqvist, Annelie Carlsson, et al.. (2008). Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetologica. 45(4). 231–235. 20 indexed citations
8.
Edsbäcker, Staffan, Bengt Bengtsson, Per Larsson, et al.. (2003). A pharmacoscintigraphic evaluation of oral budesonide given as controlled‐release (Entocort) capsules. Alimentary Pharmacology & Therapeutics. 17(4). 525–536. 86 indexed citations
9.
Carlsson, Annelie, Bo Isomaa, Aaro Miettinen, et al.. (1999). Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.. Diabetes. 48(1). 150–157. 393 indexed citations
10.
Holstein, Christer Staël von, Anna-Lena Nilsson, Stefan Andersson‐Engels, et al.. (1996). Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence.. Gut. 39(5). 711–716. 63 indexed citations
11.
Xu, Ning & Anna-Lena Nilsson. (1996). Endotoxin inhibits catabolism of low density lipoproteinsin vivo: an experimental study in the rat. Scandinavian Journal of Clinical and Laboratory Investigation. 56(1). 53–61. 6 indexed citations
12.
Xu, Ning & Anna-Lena Nilsson. (1996). Endotoxin inhibits catabolism of low density lipoproteins in vivo: an experimental study in the rat. Scandinavian Journal of Clinical and Laboratory Investigation. 56(1). 53–61. 5 indexed citations
13.
Hertervig, Erik, Anna-Lena Nilsson, & Janeric Seidegård. (1994). The Expression of Glutathione Transferase μ in Patients with Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology. 29(8). 729–735. 25 indexed citations
14.
Barros, Henrique, Berit Sternby, & Anna-Lena Nilsson. (1990). Hydrolysis of Phosphatidylinositol by Human Pancreatic Phospholipase A2. Scandinavian Journal of Gastroenterology. 25(2). 134–140. 3 indexed citations
15.
Sjögren, Anders, C.‐H. Florén, & Anna-Lena Nilsson. (1988). Evaluation of Magnesium Status in Crohn's Disease as Assessed by Intracellular Analysis and Intravenous Magnesium Infusion. Scandinavian Journal of Gastroenterology. 23(5). 555–561. 14 indexed citations
16.
Johnsson, Folke, B. Joelsson, C.‐H. Florén, & Anna-Lena Nilsson. (1988). Bile Salts in the Esophagus of Patients with Esophagitis. Scandinavian Journal of Gastroenterology. 23(6). 712–716. 44 indexed citations
17.
Landin, Britta & Anna-Lena Nilsson. (1987). Factors Affecting the Impaired Hepatic Uptake of Chylomicron Remnants in the Cholestatic Rat. Scandinavian Journal of Gastroenterology. 22(2). 225–232. 7 indexed citations
18.
Arvidson, G. & Anna-Lena Nilsson. (1972). Formation of lymph chylomicron phosphatidylcholines in the rat during the absorption of safflower oil or triolein. Lipids. 7(5). 344–348. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Multari Breakdown of academic impact, for papers by Johanne Le Beyec Breakdown of academic impact, for papers by Lars Hansen Breakdown of academic impact, for papers by Kristen A. McDaniel Breakdown of academic impact, for papers by Tarunmeet Gujral Breakdown of academic impact, for papers by Deng Ping Yin Breakdown of academic impact, for papers by Anna Casselbrant Breakdown of academic impact, for papers by Benedikt A. Aulinger Breakdown of academic impact, for papers by Jessica L. Hill Breakdown of academic impact, for papers by Marko Banić
Rankless by CCL
2026